On Monday, the US Supreme Court granted certiorari (equivalent to the Australian High Court granting special leave) in a patent case, LabCorp v. Metabolite. The case is about patentability of medical processes, and has the potential, according to the Patently-O Blog, of addressing some of the ‘patentability of processes’ issues raised in the Ex p Lundgren case that I’ve commented on before (here and here).

See Patently-O for more detail.